Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced the appointment of Giovanni Di Napoli as its new Chief Executive Officer, along with changes to its Board of Directors, at the upcoming Annual General Meeting (AGM) on 24 May 2024.
– Giovanni Di Napoli appointed as new CEO effective from 24 May 2024
– Current CEO Alessandro Della Chà to be appointed as new Chairman of the Board
– Incumbent Chairman Mauro Ajani to continue as a Board member
– Additional Board changes proposed for the upcoming AGM